Study will test favipiravir for treating COVID-19
A study will begin soon to determine whether favipiravir, an oral drug, is effective in reducing the severity of symptoms and shortening the duration of COVID-19.
Alzheimer’s Disease Research Center grant
The Stanford-based center’s affiliated faculty and staff, aided by more than 400 volunteers, conduct research on Alzheimer’s and Parkinson’s diseases and related disorders.
Potential treatment for lung fibrosis
New research suggests that lung fibrosis develops when scar tissue cells escape immune surveillance, suggesting potential therapy.
Defect in alpha cells linked to diabetes
Pancreatic alpha cells from people with diabetes release excess amounts of glucagon, a hormone important in blood sugar control, in a new Stanford-developed mouse model of transplanted human islets.
Biochemist Dale Kaiser dies
Using a virus as an experimental system, Kaiser made fundamental discoveries that were instrumental in ushering in the era of recombinant DNA technology, often known as gene splicing.